discoveric ag develops fully human bi- and multi-specific antibodies targeting Alzheimer’s disease, neuroinflammation and antimicrobial‑resistant infections. The website presents multiple programmes and a pipeline (discoveric bio alpha/beta/gamma) and notes collaboration with external experts and CROs for discovery, preclinical and clinical development.
AI-generated
Offering
Products & services
Industry:Management Consulting
✓ Offered2
Antibody development for Alzheimer
Development of fully human bi- and multispecific antibodies from discovery through preclinical and clinical development to commercialization in Alzheimer, neuroinflammation and antimicrobial resistance.
Research and development collaborations
Collaborations with partners from academia and industry, in particular for preclinical test models and the further development of bi- and multispecific antibodies.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.